Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Gout patients endorse reasons for not taking allopurinol
Patients with gout who refuse to take allopurinol for their condition do so because of their desire to lead a normal life and to test whether they could reduce the dose without experiencing any symptoms, a recent study has found.
Gout patients endorse reasons for not taking allopurinol
02 Jul 2022
Thromboxane generation tied to mortality regardless of aspirin use
Systemic thromboxane generation appears to increase the risk of all-cause and cardiovascular mortality regardless of aspirin use, reveals a study. Hence, its measurement may help inform therapy modification, especially in individuals without cardiovascular disease (CVD).
Thromboxane generation tied to mortality regardless of aspirin use
02 Jul 2022
How safe for the heart is hydroxychloroquine use in RA patients?
The risks of sudden cardiac arrest or ventricular arrythmia (SCA/VA) and major adverse cardiovascular event (MACE) are comparable between methotrexate (MTX) and hydroxychloroquine (HCQ) in older patients with rheumatoid arthritis (RA), reports a study.
How safe for the heart is hydroxychloroquine use in RA patients?
01 Jul 2022
Do bDMARDs prevent osteoporotic fractures in RA patients?
Use of biological disease-modifying antirheumatic drugs (bDMARDs) appears to have no benefit in the prevention of osteoporotic fractures among patients with rheumatoid arthritis (RA), according to the results of a recent study.
Do bDMARDs prevent osteoporotic fractures in RA patients?
01 Jul 2022
Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS
Ultra-high-dose methylcobalamin (MeCbl) slowed functional decline in individuals with early-stage amyotrophic lateral sclerosis (ALS) with moderate progression, the JETALS* study has shown.
Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS
01 Jul 2022
Novel PPARγ modulator shows therapeutic potential in acne vulgaris
In the treatment of patients with acne vulgaris, the investigational peroxisome proliferator-activated receptor-γ (PPARγ) modulator N-acetyl-GED-0507-34-LEVO (NAC-GED) 5% gel appears to help clear lesions and improve acne severity while being safe, according to the results of a phase IIb study.